David E. Griffith, MD

David E. Griffith, MD

Professor of Medicine
National Jewish Health
Denver, Colorado, USA 

CME Courses

Critical Therapeutic Advances for Optimizing Clinical Outcomes in MAC LUNG DISEASE<br><sub>Focus on ERS Guideline-Directed Use of Inhaled Antimicrobial Formulations for NTM Pulmonary Disease</sub>

Critical Therapeutic Advances for Optimizing Clinical Outcomes in MAC LUNG DISEASE
Focus on ERS Guideline-Directed Use of Inhaled Antimicrobial Formulations for NTM Pulmonary Disease

In this web-based program, physicians will learn how recent developments in basic and clinical research have helped to advance the understanding and management of non-tubercular mycobacterial (NTM) pulmonary infection with mycobacterium avium complex (MAC)

September 1, 2022

NCFBE: Clinical Evaluation and Diagnosis, Disease Management Overview, Risk Stratification, and the Role of DPP-1 Inhibition in Managing Exacerbations

NCFBE: Clinical Evaluation and Diagnosis, Disease Management Overview, Risk Stratification, and the Role of DPP-1 Inhibition in Managing Exacerbations

In this web-based program, physicians will learn about recent developments in the management of bronchiectasis.

October 30, 2022

Practical Advances in Front-Line Strategies for Optimizing Clinical Outcomes in MAC Lung Disease

Practical Advances in Front-Line Strategies for Optimizing Clinical Outcomes in MAC Lung Disease

In this web-based program, physicians will learn how recent developments in basic and clinical research have helped to advance the understanding and management of non-tubercular mycobacterial (NTM) pulmonary infection with mycobacterium avium complex (MAC)

September 3, 2023